Unknown
MDPI - Multidisciplinary Digital Publishing Institute
Publication Date:
2022-05-06
Description:
This Special Issue focuses on the current state of pharmacogenomics (PGx) and the extensive translational process, including the identification of functionally important PGx variation; the characterization of PGx haplotypes and metabolizer statuses, their clinical interpretation, clinical decision support, and the incorporation of PGx into clinical care.
Keywords:
pharmacogenomics
;
return of results
;
genetic counseling
;
qualitative
;
pharmacogenetics
;
implementation
;
pharmacogenetics service
;
screening
;
pre-emptive
;
personalized medicine
;
precision medicine
;
community pharmacy
;
pharmacogenomic testing
;
genetic privacy
;
pharmaco-economics
;
polymorphisms
;
pharmacogenes
;
pharmacogenomic
;
machine learning
;
adaptation
;
human evolution
;
US Food and Drug Administration
;
clinical actionability
;
clinical translation
;
chronic kidney disease
;
CYP3A5
;
polymorphism
;
progression
;
pharmacogenomics (PGx)
;
pediatrics
;
best practice alerts (BPAs)
;
electronic health records (EHR)
;
genomic indicators
;
clinical decision support (CDS)
;
phenotype
;
genotype
;
polypharmacy
;
chronic disease
;
medication management
;
electronic medical record
;
artificial intelligence
;
n/a
;
bic Book Industry Communication::M Medicine
;
bic Book Industry Communication::M Medicine::MM Other branches of medicine::MMG Pharmacology
Language:
English
Format:
image/jpeg
|
Location |
Call Number |
Expected |
Availability |
